Stock Earnings

Question 1

What are Eagle Pharmaceuticals Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Eagle Pharmaceuticals Inc has a total asset of $406, Net profit of $35

Question 2

What are the key financial ratios for EGRX?

Accepted Answer

Eagle Pharmaceuticals Inc's Current ratio is 2.36, has a Net margin is 11.07, sales per share of $24.12.

Question 3

How is Eagle Pharmaceuticals Inc's revenue broken down by segment or geography?

Accepted Answer

Currently Eagle Pharmaceuticals Inc data is not available.

Question 4

Is Eagle Pharmaceuticals Inc profitable?

Accepted Answer

yes, according to the latest financial statements, Eagle Pharmaceuticals Inc has a net profit of $35

Question 5

Does Eagle Pharmaceuticals Inc have any liabilities?

Accepted Answer

yes, Eagle Pharmaceuticals Inc has liability of 172

Question 6

How many outstanding shares for Eagle Pharmaceuticals Inc?

Accepted Answer

Eagle Pharmaceuticals Inc has a total outstanding shares of 13

Breakdown	TTM	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018
Revenue	257	316	171	187	195	213
Revenue Growth (YoY)	-6%	85%	-9%	-4%	-8%	-10%
Cost of Revenue	77	94	42	45	60	61
Gross Profit	179	221	129	142	135	151
Selling, General & Admin	102	85	75	78	76	60
Research & Development	35	34	51	30	36	44
Operating Expenses	143	119	126	109	113	104
Other Non Operating Income (Expenses)	5	-1	0	-8	0	--
Pretax Income	29	61	-4	22	22	34
Income Tax Expense	17	25	4	10	7	2
Net Income	12	35	-8	12	14	31
Net Income Growth	-45%	-538%	-167%	-14%	-55%	-39%
Shares Outstanding (Diluted)	13.2	13.1	13.1	13.8	14.1	15.3
Shares Change (YoY)	3%	0%	-5%	-2%	-8%	-4%
EPS (Diluted)	0.91	2.73	-0.66	0.87	1.01	2.09
EPS Growth	-49%	-514%	-176%	-14%	-52%	-36%
Free Cash Flow	-9	50	27	48	55	52
Free Cash Flow Per Share	-0.68	3.81	2.06	3.47	3.9	3.39
Gross Margin	69.64%	69.93%	75.43%	75.93%	69.23%	70.89%
Operating Margin	14%	32.27%	1.16%	17.64%	10.76%	22.06%
Profit Margin	4.66%	11.07%	-4.67%	6.41%	7.17%	14.55%
Free Cash Flow Margin	-3.5%	15.82%	15.78%	25.66%	28.2%	24.41%
EBITDA	56	114	5	36	25	50
EBITDA Margin	21.78%	36.07%	2.92%	19.25%	12.82%	23.47%
D&A For EBITDA	20	12	3	3	4	3
EBIT	36	102	2	33	21	47
EBIT Margin	14%	32.27%	1.16%	17.64%	10.76%	22.06%
Effective Tax Rate	58.62%	40.98%	-100%	45.45%	31.81%	5.88%

Eagle Pharmaceuticals Inc (EGRX) Price